2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2006

2025

Gabler N., Kirchhoff S., Sauter A., Heck Matthias, Lorenzini T., Haller B., Weber W., Eiber M., Rauscher I.. 18F-Flotufolastat PET/MR in suspicious prostate cancer: correlation with histopathological biopsy-results [Abstract]. Nuklearmedizin - Nuclear新万博体育下载_万博体育app【投注官网】icine 2025;64(1):60. https://doi.org/10.1055/s-0045-1804322 BibTeX | RIS | DOI

Knipper Sophie, Lischewsk Flemming, Koehler Daniel, Eiber Matthias, van Leeuwen Fijs W. B., de Barros Hilda, Berrens Anne-Claire, Zuur Lotte, van Leeuwen Pim J., van der Poel Henk, Ambrosini Francesca, Falkenbach Fabian, Bud?us Lars, Steuber Thomas, Graefen Markus, Tennstedt Pierre, Gschwend Jürgen E., Horn Thomas, Heck Matthias M., Maurer Tobias. Biochemical response of <0.1 ng/ml predicts therapy-free survival of prostate cancer patients following prostate-specific membrane antigen–targeted salvage surgery. European Urology Oncology 2025;8(2):270-277. https://doi.org/10.1016/j.euo.2024.04.019 PDF | BibTeX | RIS | DOI

Karimzadeh A., Fütterer C., Hansen K., Heck Matthias, Tauber R., D'Alessandria C., Weber W., Eiber M., Rauscher I.. External validation of baseline 68Ga-PSMA-11 PET-based prediction models using 18F-flotufolastat PET in patients with metastatic castration-resistant prostate cancer receiving 177Lu-labeled PSMA-targeted radioligand therapy [Abstract]. Nuklearmedizin - Nuclear新万博体育下载_万博体育app【投注官网】icine 2025;64(1):71. https://doi.org/10.1055/s-0045-1804353 BibTeX | RIS | DOI

Gammel M., Olufs C., Brosch-Lenz J., Heck Matthias, Weber W., Eiber M., Rauscher I.. Insights into renal split function assessment via PSMA-ligand PET/CT [Abstract]. Nuklearmedizin - Nuclear新万博体育下载_万博体育app【投注官网】icine 2025;64(1):79. https://doi.org/10.1055/s-0045-1804376 BibTeX | RIS | DOI

Schweiger Lilit, Maurer Tobias, Simon Ricarda, Horn Thomas, Heck Matthias M., Weber Wolfgang A., Eiber Matthias, Rauscher Isabel. Pattern of failure in patients with biochemical recurrence after PSMA radioguided surgery. Journal of Nuclear 新万博体育下载_万博体育app【投注官网】icine 2025;66(1):67-72. https://doi.org/10.2967/jnumed.124.268151 PDF | BibTeX | RIS | DOI

Karimzadeh Amir, Hansen Kimberley, Hasa Ergela, Haller Bernhard, Heck Matthias M., Tauber Robert, D'Alessandria Calogero, Weber Wolfgang A., Eiber Matthias, Rauscher Isabel. Prognostic 18F-flotufolastat PET parameters for outcome assessment of 177Lu-labeled PSMA-targeted radioligand therapy in metastatic castration-resistant prostate cancer. European Journal of Nuclear 新万博体育下载_万博体育app【投注官网】icine and Molecular Imaging 2025;52(6):2041-2050. https://doi.org/10.1007/s00259-024-07003-2 PDF | BibTeX | RIS | DOI

Falkenbach Fabian, Lischewski Flemming, Knipper Sophie, Koehler Daniel, Karakiewicz Pierre I., Tian Zhe, Saad Fred, Tilki Derya, Bud?us Lars, Steuber Thomas, Mandel Philipp, Wenzel Mike, Gschwend Jürgen E., Graefen Markus, Heck Matthias M., Maurer Tobias. Prostate-specific membrane antigen–radioguided surgery in an EMBARK-like cohort of patients with oligorecurrent hormone-sensitive prostate cancer: delay in systemic treatment. European Urology Focus 2025; https://doi.org/10.1016/j.euf.2025.01.006 BibTeX | RIS | DOI

2024

Karimzadeh Amir, Hecker Charlotte-Sophie, Heck Matthias M., Tauber Robert, D'Alessandria Calogero, Weber Wolfgang A., Eiber Matthias, Rauscher Isabel. Matched-pair analysis of mCRPC patients receiving 177Lu-labeled PSMA-targeted radioligand therapy in a 4-week versus 6-week treatment interval. EJNMMI Research 2024;14(1):94. https://doi.org/10.1186/s13550-024-01143-0 PDF | BibTeX | RIS | DOI

2023

Karimzadeh Amir, Heck Matthias, Tauber Robert, Knorr Karina, Haller Bernhard, D'Alessandria Calogero, Weber Wolfgang A., Eiber Matthias, Rauscher Isabel. 177 Lu-PSMA-I&T for treatment of metastatic castration-resistant prostate cancer: prognostic value of scintigraphic and clinical biomarkers. Journal of Nuclear 新万博体育下载_万博体育app【投注官网】icine 2023;64(3):402-409. https://doi.org/10.2967/jnumed.122.264402 PDF | BibTeX | RIS | DOI

Knipper S., Lischewski F., Koehler D., Eiber M., Van Leeuwen F. W. B., De Barros H., Berrens A., Van Leeuwen P., Van Der Poel H., Falkenbach F., Bud?us L., Steuber T., Graefen M., Gschwend J. E., Tennstedt P., Horn T., Heck Matthias M., Maurer T.. A1122 - Complete biochemical response below 0.1 ng/ml predicts long-term therapy-free survival of patients treated with salvage lymph node dissection via PSMA-radioguided surgery [Abstract]. European Urology 2023;83(Supplement 1):S1626. https://doi.org/10.1016/s0302-2838(23)01160-0 PDF | BibTeX | RIS | DOI

Knipper Sophie, Mehdi Irai Mehrdad, Simon Ricarda, Koehler Daniel, Rauscher Isabel, Eiber Matthias, van Leeuwen Fijs W. B., van Leeuwen Pim, de Barros Hilda, van der Poel Henk, Bud?us Lars, Steuber Thomas, Graefen Markus, Tennstedt Pierre, Heck Matthias M., Horn Thomas, Maurer Tobias. Cohort study of oligorecurrent prostate cancer patients: oncological outcomes of patients treated with salvage lymph node dissection via prostate-specific membrane antigen (PSMA) radioguided surgery. European Urology 2023;83(1):62-69. https://doi.org/10.1016/j.eururo.2022.05.031 PDF | BibTeX | RIS | DOI

Knipper S., Lischewski F., Koehler D., Eiber M., van Leeuwen F. W. B., de Barros H., Berrens A. C., van Leeuwen P., van der Poel H., Ambrosini F., Falkenbach F., Bud?us L., Steuber T., Graefen M., Tennstedt P., Gschwend J. E., Horn T., Heck Matthias M., Maurer T.. Complete biochemical response below 0.1 ng/ml predicts long-term therapy-free survival of prostate cancer patients treated with salvage lymph node dissection via PSMA-radioguided surgery [Abstract]. European Urology Open Science 2023;57(Supplement 1):S3. https://doi.org/10.1016/s2666-1683(23)01298-3 PDF | BibTeX | RIS | DOI

Muehlematter Urs J., Schweiger Lilit, Ferraro Daniela A., Hermanns Thomas, Maurer Tobias, Heck Matthias M., Rupp Niels J., Eiber Matthias, Rauscher Isabel, Burger Irene A.. Development and external validation of a multivariable [68Ga]Ga-PSMA-11 PET-based prediction model for lymph node involvement in men with intermediate or high-risk prostate cancer. European Journal of Nuclear 新万博体育下载_万博体育app【投注官网】icine and Molecular Imaging 2023;50(10):3137-3146. https://doi.org/10.1007/s00259-023-06278-1 PDF | BibTeX | RIS | DOI

Falkenbach Fabian, Ambrosini Francesca, Tennstedt Pierre, Eiber Matthias, Heck Matthias M., Preisser Felix, Graefen Markus, Bud?us Lars, Koehler Daniel, Knipper Sophie, Maurer Tobias. EAU biochemical recurrence risk classification and PSA kinetics have no value for patient selection in PSMA-radioguided surgery (PSMA-RGS) for oligorecurrent prostate cancer. Cancers 2023;15(20):5008. https://doi.org/10.3390/cancers15205008 PDF | BibTeX | RIS | DOI

Spohn Simon K. B., Draulans Cédric, Kishan Amar U., Spratt Daniel, Ross Ashley, Maurer Tobias, Tilki Derya, Berlin Alejandro, Blanchard Pierre, Collins Sean, Bronsert Peter, Chen Ronald, Dal Pra Alan, de Meerleer Gert, Eade Thomas, Haustermans Karin, H?lscher Tobias, H?cht Stefan, Ghadjar Pirus, Davicioni Elai, Heck Matthias M., Kerkmeijer Linda G. W., Kirste Simon, Tselis Nikolaos, Tran Phuoc T., Pinkawa Michael, Pommier Pascal, Deltas Constantinos, Schmidt-Hegemann Nina-Sophie, Wiegel Thomas, Zilli Thomas, Tree Alison C., Qiu Xuefeng, Murthy Vedang, Epstein Jonathan I., Graztke Christian, Gao Xin, Grosu Anca L., Kamran Sophia C., Zamboglou Constantinos. Genomic classifiers in personalized prostate cancer radiation therapy approaches: a systematic review and future perspectives based on international consensus. International Journal of Radiation Oncology*Biology*Physics 2023;116(3):503-520. https://doi.org/10.1016/j.ijrobp.2022.12.038 PDF | BibTeX | RIS | DOI

Groeben Christer, Boehm Katharina, Koch Rainer, Sonntag Ulrich, Nestler Tim, Struck Julian, Heck Matthias, Baunacke Martin, Uhlig Annemarie, Koelker Mara, Meyer Christian P., Becker Benedikt, Salem Johannes, Huber Johannes, Leitsmann Marianne. Hospital rating websites play a minor role for uro-oncologic patients when choosing a hospital for major surgery: results of the German multicenter NAVIGATOR-study. World Journal of Urology 2023;41(2):601-609. https://doi.org/10.1007/s00345-022-04271-1 PDF | BibTeX | RIS | DOI

Hekimsoy T., Heck Matthias M., Gschwend J. E., Schwamborn K., Eiber M., Weber W.. How many unnecessary prostate biopsies can be avoided by PSMA PET/MR? [Abstract]. Nuklearmedizin - Nuclear新万博体育下载_万博体育app【投注官网】icine 2023;62(2):97. https://doi.org/10.1055/s-0043-1766180 BibTeX | RIS | DOI

Karimzadeh A., Soeiro P., Feuerecker B., Heck Matthias M., Tauber R., Knorr K., D'Alessandria C., Weber W., Eiber M., Rauscher I.. Improved quality of life in mCRPC patients receiving consecutive cycles of 177Lu-PSMA RLT [Abstract]. Nuklearmedizin - Nuclear新万博体育下载_万博体育app【投注官网】icine 2023;62(2):109. https://doi.org/10.1055/s-0043-1766217 BibTeX | RIS | DOI

Karimzadeh Amir, Soeiro Paula, Feuerecker Benedikt, Hecker Charlotte-Sophie, Knorr Karina, Heck Matthias M., Tauber Robert, D'Alessandria Calogero, Weber Wolfgang, Eiber Matthias, Rauscher Isabel. Improved quality of life in metastatic castration-resistant prostate cancer patients receiving consecutive cycles of 177Lu-PSMA I&T. Journal of Nuclear 新万博体育下载_万博体育app【投注官网】icine 2023;64(11):1765-1771. https://doi.org/10.2967/jnumed.123.265878 PDF | BibTeX | RIS | DOI

Jahnen Matthias, Heck Matthias M.. Kommentar zu: Radikale Prostatektomie beim oligometastasierten Prostatakarzinom. Aktuelle Urologie 2023;54(4):262-264. https://doi.org/10.1055/a-2060-4417 BibTeX | RIS | DOI

Ambrosini Francesca, Falkenbach Fabian, Bud?us Lars, Graefen Markus, Koehler Daniel, Lischewski Flemming, Gschwend Juergen E., Heck Matthias M., Eiber Matthias, Knipper Sophie, Maurer Tobias. Prevalence of bilateral loco-regional spread in unilateral pelvic PSMA PET positive recurrent prostate cancer. Minerva Urology and Nephrology 2023;75(6):734-742. https://doi.org/10.23736/s2724-6051.23.05445-9 BibTeX | RIS | DOI

Meagher Margaret F., Mir Maria C., Minervini Andrea, Kriegmair Maximilian, Heck Matthias M., Porpiglia Francesco, Van Bruwaene Siska, Linares Estefania, Hevia Vital, D'Anna Maurizio, Veccia Alessandro, Roussel Eduard, Claps Francesco, Palumbo Carlotta, Marchioni Michele, Afari Jonathan, Saitta Cesare, Liu Franklin, Rubio Jose, Campi Riccardo, Mari Andrea, Amiel Thomas, Checcucci Enrico, Musquera Mireia, Guruli Georgi, Pavan Nicola, Albersen Maarten, Antonelli Alessandro, Klatte Tobias, Autorino Riccardo, McKay Rana R., Derweesh Ithaar H.. Proposal for a two-tier re-classification of stage IV/M1 domain of renal cell carcinoma into M1 ("oligometastatic") and M2 ("polymetastatic") subdomains: analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC). Frontiers in Oncology 2023;13:1113246. https://doi.org/10.3389/fonc.2023.1113246 PDF | BibTeX | RIS | DOI

Lunger Lukas, Steinhelfer Lisa, Korn Philipp, Eiber Matthias, Maurer Tobias, Büchler Jakob, Horn Thomas, Gschwend Jürgen E., Heck Matthias M.. Prostate-specific membrane antigen–radioguided surgery facilitates pelvic lymph node dissection during radical prostatectomy for the treatment of locally advanced prostate cancer with regional lymph node metastases. European Urology Oncology 2023;6(1):95-98. https://doi.org/10.1016/j.euo.2022.12.001 PDF | BibTeX | RIS | DOI

Falkenbach Fabian, Knipper Sophie, Koehler Daniel, Ambrosini Francesca, Steuber Thomas, Graefen Markus, Bud?us Lars, Eiber Matthias, Lunger Lukas, Lischewski Flemming, Heck Matthias M., Maurer Tobias. Safety and efficiency of repeat salvage lymph node dissection for recurrence of prostate cancer using PSMA-radioguided surgery (RGS) after prior salvage lymph node dissection with or without initial RGS support. World Journal of Urology 2023;41(9):2343-2350. https://doi.org/10.1007/s00345-023-04534-5 PDF | BibTeX | RIS | DOI

Seifert Robert, Emmett Louise, Rowe Steven P., Herrmann Ken, Hadaschik Boris, Calais Jeremie, Giesel Frederik L., Reiter Robert, Maurer Tobias, Heck Matthias M., Gafita Andrei, Morris Michael J., Fanti Stefano, Weber Wolfgang A., Hope Thomas A., Hofman Michael S., Fendler Wolfgang Peter, Eiber Matthias. Second version of the prostate cancer molecular imaging standardized evaluation framework including response evaluation for clinical trials (PROMISE?V2). European Urology 2023;83(5):405-412. https://doi.org/10.1016/j.eururo.2023.02.002 PDF | BibTeX | RIS | DOI

Karimzadeh Amir, Heck Matthias M., Tauber Robert, Solaris Esteban, Nekolla Stephan, Knorr Karina, Haller Bernhard, D'Alessandria Calogero, Weber Wolfgang A., Eiber Matthias, Rauscher Isabel. The impact of PSMA PET–based eligibility criteria used in the prospective phase II TheraP trial in metastatic castration-resistant prostate cancer patients undergoing prostate-specific membrane antigen–targeted radioligand therapy. Journal of Nuclear 新万博体育下载_万博体育app【投注官网】icine 2023;64(8):1252-1258. https://doi.org/10.2967/jnumed.122.265346 PDF | BibTeX | RIS | DOI

Lunger Lukas, Eiber Matthias, Heck Matthias M.. Theranostik. In: Merseburger Axel S., Roesch Marie C., editors. Metastasiertes Prostatakarzinom: Diagnostik und Therapie. Berlin: Springer; 2023. p. 93-99. https://doi.org/10.1007/978-3-662-67297-6_9 PDF | BibTeX | RIS | DOI

Herms Elena, Weirich Gregor, Maurer Tobias, Wagenpfeil Stefan, Preuss Stephanie, Sauter Andreas, Heck Matthias, G?rtner Anita, Hauner Katharina, Autenrieth Michael, Kübler Hubert P., Holzapfel Konstantin, Schwarz-Boeger Ulrike, Heemann Uwe, Slotta-Huspenina Julia, Stock Konrad Friedrich. Ultrasound-based "CEUS-Bosniak" classification for cystic renal lesions: an 8-year clinical experience. World Journal of Urology 2023;41(3):679-685. https://doi.org/10.1007/s00345-022-04094-0 PDF | BibTeX | RIS | DOI

2022

Zaum R., Hein S., Rauscher I., Weber W. A., Gafita A., Heck Matthias, Eiber M.. 177-Lu-PSMA I&T therapy in patients with metastatic castration-resistant prostate cancer (mCRPC): evaluation of treatment response using PSMA-ligand PET/CT [Abstract]. Nuklearmedizin - Nuclear新万博体育下载_万博体育app【投注官网】icine 2022;61(2):191-192. https://doi.org/10.1055/s-0042-1746100 BibTeX | RIS | DOI

Ilhan Harun, Kroenke Markus, Wurzer Alexander, Unterrainer Marcus, Heck Matthias, Belka Claus, Knorr Karina, Langbein Thomas, Rauscher Isabel, Schmidt-Hegemann Nina-Sophie, Schiller Kilian, Bartenstein Peter, Wester Hans-Jürgen, Eiber Matthias. 18F-rhPSMA-7 PET for the detection of biochemical recurrence of prostate cancer after curative-intent radiation therapy: a bicentric retrospective study. Journal of Nuclear 新万博体育下载_万博体育app【投注官网】icine 2022;63(8):1208-1214. https://doi.org/10.2967/jnumed.121.262861 PDF | BibTeX | RIS | DOI

Herms E., Slotta-Huspenin J., G?rtner A., Preuss S., Hauner K., Heck Matthias, Autenrieth M., Maurer T., Kübler H., Holzapfel K., Sauter A., Schwarz-Boeger U., Wagenpfeil S., Heemann U., Stock K. F.. A0053 - Ultrasound based CEUS-Bosniak classification for cystic renal lesions: an 8-year clinical experience [Abstract]. European Urology 2022;81(Supplement 1):S77-S78. https://doi.org/10.1016/s0302-2838(22)00141-5 PDF | BibTeX | RIS | DOI

Groeben C., Boehm K., Sonntag U., Nestler T., Struck J., Heck Matthias, Baunacke M., Uhlig A., Koelker M., Meyer C. P., Becker B., Salem J., Huber J., Leitsmann M.. A0088 - Hospital rating websites play a minor role in hospital choice of uro-oncologic patients in Germany: results of the multicentric NAVIGATOR-study [Abstract]. European Urology 2022;81(Supplement 1):S131. https://doi.org/10.1016/s0302-2838(22)00176-2 PDF | BibTeX | RIS | DOI

Knipper S., Mehdi Irai M., Simon R., K?hler D., Isabel R., Eiber M., Van Leeuwen F. W. B., Van Leeuwen P., Bud?us L., Steuber T., Graefen M., Tennstedt P., Heck Matthias, Horn T., Maurer T.. A0511 - Cohort study of oligorecurrent prostate cancer patients: oncological outcomes of patients treated with salvage lymph node dissection via PSMA radioguided surgery [Abstract]. European Urology 2022;81(Supplement 1):S767. https://doi.org/10.1016/s0302-2838(22)00594-2 PDF | BibTeX | RIS | DOI

Maurer Tobias, Mehdi Irai Mehrdad, Rauscher Isabel, Simon Ricarda, Eiber Matthias, van Leeuwen Fijs W. B., van Leeuwen Pim, Budaeus Lars, Steuber Thomas, Graefen Markus, Tennstedt Pierre, Heck Matthias, Horn Thomas, Knipper Sophie. Cohort study of oligorecurrent prostate cancer patients: oncological outcomes of patients treated with salvage lymph node dissection via PSMA radioguided surgery [Abstract]. Journal of Clinical Oncology 2022;40(6, supplement):106. https://doi.org/10.1200/jco.2022.40.6_suppl.106 BibTeX | RIS | DOI

Babst Christa, Amiel Thomas, Maurer Tobias, Knipper Sophie, Lunger Lukas, Tauber Robert, Retz Margitta, Herkommer Kathleen, Eiber Matthias, von Amsberg Gunhild, Graefen Markus, Gschwend Juergen, Steuber Thomas, Heck Matthias. Cytoreductive radical prostatectomy after chemohormonal therapy in patients with primary metastatic prostate cancer. Asian Journal of Urology 2022;9(1):69-74. https://doi.org/10.1016/j.ajur.2021.04.003 PDF | BibTeX | RIS | DOI

Karimzadeh A., Schweiger L., Wehrstedt R., Heck Matthias, Tauber R., Haller B., Gschwend J. E., Knorr K., D'Alessandria C., Weber W. A., Eiber M., Rauscher I.. Evaluation of the prognostic value of the PET eligibility criteria of the TheraP trial [Abstract]. Nuklearmedizin - Nuclear新万博体育下载_万博体育app【投注官网】icine 2022;61(2):150. https://doi.org/10.1055/s-0042-1745978 BibTeX | RIS | DOI

Harke Nina N., Wagner Christian, Hermann Robert M., Hadaschik Boris A., Radtke Jan Philipp, Altay-Langguth Alev, Aufderklamm Stefan, Bach Christian, Becker-Schiebe Martina, Blana Andreas, Bruns Frank, Buse Stephan, Combs Stephanie E., Engels Christina L., Ezzibdeh Emad, Fiedler Marcel, Fischer Laura-Anna, Farzat Mahmoud, Frismann Alexander, Heck Matthias M., Henkenberens Christoph, Roesch Marie C., K?ding Christoph, Klautke Gunther, Krausewitz Philipp, Kuczyk Markus A., Leitsmann Conrad, Lettmaier Sebastian, Mahjoub Samy, Manseck Andreas, 新万博体育下载_万博体育app【投注官网】enwald Daniel, Meyer Andreas, Micke Oliver, Moritz Rudolf, Ott Marcel, Peters Inga, Pokupic Sasa, Porres Daniel, Preisser Felix, Reichel Kathrin, Schneider Andreas, Schwentner Christian, Scobioala Sergiu, Truss Michael, Wegener Daniel, Wezel Felix, Willborn Kay, Witt J?rn H., Wittig Andrea, Wittlinger Michael, Wolff Hendrik A., Zimmermanns Volker, Christiansen Hans. Lessons learned after one year of COVID-19 from a urologist and radiotherapist view: a German survey on prostate cancer diagnosis and treatment. PLoS ONE 2022;17(6):e0269827. https://doi.org/10.1371/journal.pone.0269827 PDF | BibTeX | RIS | DOI

Meissner Valentin H., Rauscher Isabel, Schwamborn Kristina, Neumann Jan, Miller Gregor, Weber Wolfgang, Gschwend Jürgen E., Eiber Matthias, Heck Matthias M.. Radical prostatectomy without prior biopsy following multiparametric magnetic resonance imaging and prostate-specific membrane antigen positron emission tomography. European Urology 2022;82(2):156-160. https://doi.org/10.1016/j.eururo.2021.11.019 PDF | BibTeX | RIS | DOI

Meissner Valentin H., Gschwend Jürgen E., Heck Matthias M.. Reply to Giancarlo Marra, Armando Stabile, Paolo Gontero, Francesco Montorsi, Alberto Briganti, and Giorgio Gandaglia's Letter to the Editor re: Valentin H. Meissner, Isabel Rauscher, Kristina Schwamborn, et al. Radical prostatectomy without prior biopsy following multiparametric magnetic resonance imaging and prostate-specific membrane antigen positron emission tomography. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.11.019: A Storm in a Teacup [Letter]. European Urology 2022;81(5):e117. https://doi.org/10.1016/j.eururo.2022.01.039 PDF | BibTeX | RIS | DOI

2021

Marchioni Michele, Cheaib Joseph G., Takagi Toshio, Pavan Nicola, Antonelli Alessandro, Everaerts Wourter, Heck Matthias, Rha Koon H., Mottrie Alexandre, Kaouk Jihad, Capitanio Umberto, Lima Estev?o, Veccia Alessandro, Crivellaro Simone, Linares Estefania, Celia Antonio, Porpiglia Francesco, Autorino Riccardo, Di Nicola Marta, Schips Luigi, Pierorazio Phillip M., Mir Maria Carmen. Active surveillance for small renal masses in elderly patients does not increase overall mortality rates compared to primary intervention: a propensity score weighted analysis. Minerva Urology and Nephrology 2021;73(6):781-788. https://doi.org/10.23736/s2724-6051.20.03785-6 BibTeX | RIS | DOI

Feuerecker Benedikt, Tauber Robert, Knorr Karina, Heck Matthias, Beheshti Ali, Seidl Christof, Bruchertseifer Frank, Pickhard Anja, Gafita Andrei, Kratochwil Clemens, Retz Margitta, Gschwend Jürgen E., Weber Wolfgang A., D'Alessandria Calogero, Morgenstern Alfred, Eiber Matthias. Activity and adverse events of Actinium-225-PSMA-617 in advanced metastatic castration-resistant prostate cancer after failure of Lutetium-177-PSMA. European Urology 2021;79(3):343-350. https://doi.org/10.1016/j.eururo.2020.11.013 PDF | BibTeX | RIS | DOI

Marchioni Michele, Kriegmair Maximilian, Heck Matthias, Amiel Thomas, Porpiglia Francesco, Ceccucci Enrico, Campi Riccardo, Minervini Andrea, Mari Andrea, Van Bruwaene Siska, Linares Estefania, Hevia Vital, Musquera Mireia, D’Anna Mauricio, Derweesh Ithaar, Bradshaw Aaron, Autorino Riccardo, Guruli Georgi, Veccia Alessandro, Roussel Eduard, Albersen Maarten, Pavan Nicola, Claps Francesco, Antonelli Alessandro, Palumbo Carlotta, Klatte Tobias, Erdem Selcuk, Mir Maria Carmen. Development of a novel risk score to select the optimal candidate for cytoreductive nephrectomy among patients with metastatic renal cell carcinoma: results from a multi-institutional registry (REMARCC). European Urology Oncology 2021;4(2):256-263. https://doi.org/10.1016/j.euo.2020.12.010 PDF | BibTeX | RIS | DOI Published in collaboration with EAU-Young Academic Urologist Kidney Cancer Group. Please see publisher's website for further details.

Lunger Lukas, Retz Margitta, Bandur Miriam, Souchay Marc, Vitzthum Elisabeth, J?ger Marion, Weirich Gregor, Schuster Tibor, Autenrieth Michael, Kübler Hubert, Maurer Tobias, Thalgott Mark, Herkommer Kathleen, Koll Florestan, Gschwend Jürgen E., Nawroth Roman, Heck Matthias M.. KLK3 and TMPRSS2 for molecular lymph-node staging in prostate cancer patients undergoing radical prostatectomy. Prostate Cancer and Prostatic Diseases 2021;24(2):362-369. https://doi.org/10.1038/s41391-020-00283-3 PDF | BibTeX | RIS | DOI

Wuernschimmel Christoph, Amiel Thomas, Heck Matthias, Horn Thomas, Nguyen Noemi, Budaeus Lars, Knipper Sophie, Wenzel Mike, Rauscher Isabel, Eiber Matthias, Wang Hui, Maurer Tobias. MP11-12 Regional lymph node metastasis on PSMA PET correlates with decreased BCR-free and therapy-free survival after radical prostatectomy [Abstract]. Journal of Urology 2021;206(Supplement 3):MP11-MP12. https://doi.org/10.1097/ju.0000000000001984.12 BibTeX | RIS | DOI

Knipper Sophie, von Amsberg Gunhild, Stolzenbach Franziska, Steuber Thomas, Heck Matthias, Eiber Matthias, Berliner Christoph, Maurer Tobias. Multimodal therapy in oligometastatic prostate cancer: a glimpse into the future? [Letter]. Asian Journal of Urology 2021;8(2):248-250. https://doi.org/10.1016/j.ajur.2020.05.001 PDF | BibTeX | RIS | DOI

Lunger Lukas, Tauber Robert, Feuerecker Benedikt, Gschwend Jürgen E., Eiber Matthias, Heck Matthias M.. Narrative review: prostate-specific membrane antigen-radioligand therapy in metastatic castration-resistant prostate cancer. Translational Andrology and Urology 2021;10(10):3963-3971. https://doi.org/10.21037/tau-20-1135 PDF | BibTeX | RIS | DOI

Maisch Phillipp, Lunger Lukas, Düwel Charlotte, Schmid Sebastian C., Horn Thomas, Gschwend Jürgen E., Sauter Andreas, Heck Matthias M.. Outcomes of palliative cystectomy in patients with locally advanced pT4 bladder cancer. Urologic Oncology: Seminars and Original Investigations 2021;39(6):368.e11-368.e17. https://doi.org/10.1016/j.urolonc.2020.11.042 PDF | BibTeX | RIS | DOI

Schiller Kilian, St?hrer Lucia, Düsberg Mathias, Borm Kai, Devecka Michal, Vogel Marco M. E., Tauber Robert, Heck Matthias M., Rauscher Isabel, Eiber Matthias, Gschwend Jürgen E., Duma Marciana Nona, Combs Stephanie E.. PSMA-PET/CT–based lymph node atlas for prostate cancer patients recurring after primary treatment: clinical implications for salvage radiation therapy. European Urology Oncology 2021;4(1):73-83. https://doi.org/10.1016/j.euo.2020.04.004 PDF | BibTeX | RIS | DOI

Karimzadeh A., Heck Matthias, Gschwend J. E., Weber W. A., Eiber M., Rauscher I.. PSMA-ligand uptake in posttherapeutic 177Lu-PSMA scintigraphy to assess response in patients with mCRPC [Abstract]. Nuklearmedizin - Nuclear新万博体育下载_万博体育app【投注官网】icine 2021;60(2):183-184. https://doi.org/10.1055/s-0041-1726861 BibTeX | RIS | DOI

Amiel Thomas, Würnschimmel Christoph, Heck Matthias, Horn Thomas, Nguyen Noemi, Bud?us Lars, Knipper Sophie, Wenzel Mike, Rauscher Isabel, Eiber Matthias, Wang Hui, Maurer Tobias. Regional lymph node metastasis on prostate specific membrane antigen positron emission tomography correlates with decreased biochemical recurrence-free and therapy-free survival after radical prostatectomy: a retrospective single-center single-arm observational study. Journal of Urology 2021;205(6):1663-1670. https://doi.org/10.1097/ju.0000000000001596 BibTeX | RIS | DOI

Knipper Sophie, Ascalone Luigi, Ziegler Benjamin, Hohenhorst Jan L., Simon Ricarda, Berliner Christoph, van Leeuwen Fijs W. B., van der Poel Henk, Giesel Frederik, Graefen Markus, Eiber Matthias, Heck Matthias M., Horn Thomas, Maurer Tobias. Salvage surgery in patients with local recurrence after radical prostatectomy. European Urology 2021;79(4):537-544. https://doi.org/10.1016/j.eururo.2020.11.012 PDF | BibTeX | RIS | DOI

Storz Enno, Heck Matthias. Supportive Therapie und Begleitma?nahmen beim Einsatz von Onkologika. In: Merseburger Axel S., Kramer Mario Wolfgang, editors. 新万博体育下载_万博体育app【投注官网】ikamente in der Urologie. Berlin: Springer; 2021. p. 509-518. https://doi.org/10.1007/978-3-662-61492-1_25 PDF | BibTeX | RIS | DOI

2020

Mir Maresma M. C., Marchioni M., Campi R., Minervini A., Kriegmair M., Heck Matthias, Porpiglia F., Van Bruwaene S., Linares E., Hevia V., Musquera M., Derweesh I., Ghali F., Autorino R., Veccia A., Roussel E., Albertsen M., Pavan N., Antonellia A., Palumbo C., Capitanio U., Klatte T., Erdem S., Rubio-Briones J.. 836 - Performance of a new risk assessment tool for patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy in the targeted therapy era: REMARCC score [Abstract]. European Urology Open Science 2020;19(Supplement 2):e1266-e1267. https://doi.org/10.1016/s2666-1683(20)33434-0 PDF | BibTeX | RIS | DOI Published on behalf of the YAU Renal Cancer Group. Please see publisher's website for further details.

Roussel E., Campi R., Minervini A., Kriegmair M., Heck Matthias, Klatte T., Kara ?., Bertolo R., Erdem S., Capitanio U., Van Bruwaene S., Albersen M., Linares E., Antonelli A., Rubio J., Pavan N., Autorino R., Derweesh I., Musqueara M., Hevia V., Porpiglia F., Ouzaid I., Mir M. C.. 837 - Predictors for perioperative complications in cytoreductive nephrectomy: analysis of the registry for metastatic RCC (REMARCC) [Abstract]. European Urology Open Science 2020;19(Supplement 2):e1268-e1269. https://doi.org/10.1016/s2666-1683(20)33435-2 PDF | BibTeX | RIS | DOI Published on behalf of the Young Academic Urologists Renal Cancer Working Group. Please see publisher's website for further details.

Campi R., Marchioni M., Roussel E., Capitanio U., Klatte T., Kriegmair M., Erdem S., Rubio-Briones J., Minervini A., Heck Matthias, Porpiglia F., Van Bruwaene S., Linares E., Hevia V., Musquera M., Derweesh I., Autorino R., Pavan N., Antonelli A., Palumbo C., Guruli G., Ghali F., Amiel T., Mir M.. 840 - Minimally invasive versus open cytoreductive nephrectomy for primary metastatic renal cancer: a multi-institutional experience from the REMARCC registry [Abstract]. European Urology Open Science 2020;19(Supplement 2):e1274-e1275. https://doi.org/10.1016/s2666-1683(20)33438-8 PDF | BibTeX | RIS | DOI Published on behalf of the YAU Renal Cancer Group. Please see publisher's website for further details.

Marchioni M., Campi R., Minervini A., Klatte T., Kriegmair M., Erdem S., Capitanio U., Roussel E., Albertsen M., Heck Matthias, Porpiglia F., Van Bruwaene S., Linares E., Hevia V., Musquera M., Derweesh I., Autorino R., Pavan N., Antonelli A., Rubio-Briones J., Vecchia A., Checcucci E., Claps F., Mir M. C.. 841 - The impact of sarcomatoid features on survival outcomes in metastatic renal cell carcinoma patients receiving upfront cytoreductive nephrectomy: a retrospective analysis of a contemporary series [Abstract]. European Urology Open Science 2020;19(Supplement 2):e1276-e1277. https://doi.org/10.1016/s2666-1683(20)33439-x PDF | BibTeX | RIS | DOI Published on behalf of the YAU Renal Cancer Group. Please see publisher's website for further details.

Meagher M. F., Mir M., Rubio J., Campi R., Minervini A., Mari A., Kriegmair M., Heck Matthias, Amiel T., Van Bruwaene S., Porpiglia F., Checcucci E., Linares E., Hevia V., Musquera M., Bradshaw A., Ghali F., Patel D., Autorino R., Rousel E., Pavan N., Antonelli A., Marchioni M., McKay R., Derweesh I.. 842 - Proposal for a two-tier re-classification of stage IV/M1 renal cell carcinoma into M1 (oligometastatic) and M2 (polymetastatic) sub stages [Abstract]. European Urology Open Science 2020;19(Supplement 2):e1278-e1279. https://doi.org/10.1016/s2666-1683(20)33440-6 PDF | BibTeX | RIS | DOI

Meagher M. F., Mir M., Rubio J., Campi R., Minervini A., Kriegmair M., Heck Matthias, Van Bruwaene S., Linares E., Hevia V., Musquera M., D'Anna M., Ghali F., Patel D., Bradshaw A., Autorino R., Guruli G., Rousel E., Albertsen M., Pavan N., Claps F., Antonelli A., Palumbo C., Marchioni M., Derweesh I.. 846 - Impact of metastasectomy on cancer specific and overall survival in metastatic renal cell carcinoma: analysis of the REMARCC registry [Abstract]. European Urology Open Science 2020;19(Supplement 2):e1285-e1286. https://doi.org/10.1016/s2666-1683(20)33444-3 PDF | BibTeX | RIS | DOI

Gafita Andrei, Heck Matthias M., Rauscher Isabel, Tauber Robert, Cala Lisena, Franz Charlott, D'Alessandria Calogero, Retz Margitta, Weber Wolfgang A., Eiber Matthias. Early prostate-specific antigen changes and clinical outcome following 177 Lu-PSMA radionuclide treatment in patients with metastatic castration-resistant prostate cancer. Journal of Nuclear 新万博体育下载_万博体育app【投注官网】icine 2020;61(10):1476-1483. https://doi.org/10.2967/jnumed.119.240242 PDF | BibTeX | RIS | DOI

Heck Matthias M., Gschwend Jürgen E.. Extended lymph node dissection for bladder cancer: do clinical trials rule out a benefit?. European Urology Focus 2020;6(4):617-619. https://doi.org/10.1016/j.euf.2019.08.003 PDF | BibTeX | RIS | DOI

Meagher Margaret Frances, Autorino Ricardo, Kriegmair Maximilian, Mir Maria Carmen, Rubio Jose, Campi Riccardo, Mari Andrea, Heck Matthias, Porpiglia Francesco, Van Bruwaene Siska, Linares Espinos Estefania, Musquera Mireia, Ghali Fadi, Veccia Alessandro, Guruli Georgi, Rousel Eduard, Pavan Nicola, Antonelli Alessandro, Marchioni Michele, Derweesh Ithaar. Impact of metastasectomy on progression free and overall survival in metastatic renal cell carcinoma: analysis of the REMARCC registry [Abstract]. Journal of Clinical Oncology 2020;38(6_suppl):753. https://doi.org/10.1200/jco.2020.38.6_suppl.753 BibTeX | RIS | DOI

Mir M. Carmen, Marchioni Michele, Campi Riccardo, Minervini Andrea, Roussel Eduard, Albertsen Maarteen, Capitanio Umberto, Klatte Tobias, Maximilian Kriegmair, Erdem Selcuk, Rubio-Briones Jose, Heck Matthias, Porpiglia Francesco, Checcucci Enrico, Van Bruwaene Siska, Linares Estefania, Hevia Vital, Musquera Mireia, Musquera Mireia, D'Anna Mauricio, Derweesh Ithaar, Meagher Margaret F., Ghali Fadi, Autorino Riccardo, Vecchia Alessandro, Guruli Georgi, Pavan Nicola, Claps Francesco, Antonelli Alessandro, Palumbo Carlotta, Antonelli Alessandro. MP14-07 Performance of a new risk assessment tool for patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy in the targeted therapy era: REMARCC score [Abstract]. Journal of Urology 2020;203(Supplement 4):e197. https://doi.org/10.1097/ju.0000000000000839.07 BibTeX | RIS | DOI

Heck Matthias M., Koll Florestan J., Retz Margitta, Autenrieth Michael, Magg Kathrin, Lunger Lukas, Gschwend Jürgen E., Nawroth Roman. Molecular lymph node staging for bladder cancer patients undergoing radical cystectomy with pelvic lymph node dissection. Urologic Oncology: Seminars and Original Investigations 2020;38(7):639.e11-639.e19. https://doi.org/10.1016/j.urolonc.2020.01.018 PDF | BibTeX | RIS | DOI

Heck Matthias, Gschwend Jürgen E., Eiber Matthias. PSMA-Theranostik beim Prostatakarzinom. Uro-News 2020;24(10):42-51. https://doi.org/10.1007/s00092-020-4210-x BibTeX | RIS | DOI

Roussel Eduard, Campi Riccardo, Larcher Alessandro, Verbiest Annelies, Antonelli Alessandro, Palumbo Carlotta, Derweesh Ithaar, Ghali Fady, Bradshaw Aaron, Meagher Margaret F., Heck Matthias, Amiel Thomas, Kriegmair Maximilian C., Rubio Jose, Musquera Mireia, D'Anna Maurizio, Autorino Riccardo, Guruli Georgi, Veccia Alessandro, Linares-Espinos Estefania, Van Bruwaene Siska, Hevia Vital, Porpiglia Francesco, Checcucci Enrico, Minervini Andrea, Mari Andrea, Pavan Nicola, Claps Francesco, Marchioni Michele, Capitanio Umberto, Beuselinck Benoit, Mir Maria C., Albersen Maarten. Rates and predictors of perioperative complications in cytoreductive nephrectomy: analysis of the Registry for Metastatic Renal Cell Carcinoma. European Urology Oncology 2020;3(4):523-529. https://doi.org/10.1016/j.euo.2020.04.006 PDF | BibTeX | RIS | DOI Published on behalf of the Young Academic Urologists Renal Cell Carcinoma Working Group. Please see publisher's website for further details.

Marchioni M., Campi R., Minervini A., Klatte T., Kriegmair M. C., Erdem S., Capitanio U., Roussel E., Albertsen M., Heck Matthias, Porpiglia F., Van Bruwaene S., Linares E., Hevia V., Musquera M., Darweesh I., Autorino R., Pavan N., Antonelli A., Rubio-Briones J., Veccia A., Checcucci E., Claps F., Mir C.. SC177 - The impact of sarcomatoid features on survival outcomes in metastatic renal cell carcinoma patients receiving upfront cytoreductive nephrectomy: a retrospective analysis of a contemporary series [Abstract]. European Urology Open Science 2020;20(Supplement 2):S115. https://doi.org/10.1016/s2666-1683(20)35499-9 PDF | BibTeX | RIS | DOI

Heidegger Isabel, Brandt Maximilian P., Heck Matthias M.. Treatment of non-metastatic castration resistant prostate cancer in 2020: what is the best?. Urologic Oncology: Seminars and Original Investigations 2020;38(4):129-136. https://doi.org/10.1016/j.urolonc.2019.11.007 PDF | BibTeX | RIS | DOI

Maurer Tobias, Knipper Sophie, Heck Matthias M., Horn Thomas, Berliner Christoph, K?hler Daniel, Kr?nke Markus, Rauscher Isabel, Eiber Matthias. [99mTc]Tc-PSMA-I&S: Anwendung zur Radioguided Surgery beim rezidivierten Prostatakarzinom. Der Nuklearmediziner 2020;43(4):309-315. https://doi.org/10.1055/a-1105-8039 BibTeX | RIS | DOI

2019

Maurer Tobias, Robu Stephanie, Schottelius Margret, Schwamborn Kristina, Rauscher Isabel, van den Berg Nynke S., van Leeuwen Fijs W. B., Haller Bernhard, Horn Thomas, Heck Matthias M., Gschwend Jürgen E., Schwaiger Markus, Wester Hans-Jürgen, Eiber Matthias. 99mTechnetium-based prostate-specific membrane antigen–radioguided surgery in recurrent prostate cancer. European Urology 2019;75(4):659-666. https://doi.org/10.1016/j.eururo.2018.03.013 PDF | BibTeX | RIS | DOI

Gafita Andrei, Rauscher Isabel, Retz Margitta, Knorr Karina, Heck Matthias, Wester Hans-Jürgen, D'Alessandria Calogero, Weber Wolfgang A., Eiber Matthias, Tauber Robert. Early experience of rechallenge 177Lu-PSMA radioligand therapy after an initial good response in patients with advanced prostate cancer. Journal of Nuclear 新万博体育下载_万博体育app【投注官网】icine 2019;60(5):644-648. https://doi.org/10.2967/jnumed.118.215715 PDF | BibTeX | RIS | DOI

Gschwend Jürgen E., Heck Matthias M., Lehmann Jan, Rübben Herbert, Albers Peter, Wolff Johannes M., Frohneberg Detlef, de Geeter Patrick, Heidenreich Axel, K?lble Tilman, St?ckle Michael, Schn?ller Thomas, Stenzl Arnulf, Müller Markus, Truss Michael, Roth Stephan, Liehr Uwe-Bernd, Lei?ner Joachim, Bregenzer Thomas, Retz Margitta. Extended versus limited lymph node dissection in bladder cancer patients undergoing radical cystectomy: survival results from a prospective, randomized trial. European Urology 2019;75(4):604-611. https://doi.org/10.1016/j.eururo.2018.09.047 PDF | BibTeX | RIS | DOI

Seitz A. K., Heck Matthias M., Kamer M. W., Grüllich C.. Molekulares Tumorboard Prostatakarzinom. Der Urologe 2019;58(7):752-759. https://doi.org/10.1007/s00120-019-0933-2 PDF | BibTeX | RIS | DOI

Gschwend Jürgen E., Heck Matthias. Reply to Satoru Taguchi, Tohru Nakagawa, and Hiroshi Fukuhara's Letter to the Editor re: Jürgen E. Gschwend, Matthias M. Heck, Jan Lehmann, et al. Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial. Eur Urol 2019;75:604–11 [Letter]. European Urology 2019;76(2):e37. https://doi.org/10.1016/j.eururo.2019.04.032 PDF | BibTeX | RIS | DOI

Horn Thomas, Kr?nke Markus, Rauscher Isabel, Haller Bernhard, Robu Stephanie, Wester Hans-Jürgen, Schottelius Margret, van Leeuwen Fijs W. B., van der Poel Henk G., Heck Matthias, Gschwend Jürgen E., Weber Wolfgang, Eiber Matthias, Maurer Tobias. Single lesion on prostate-specific membrane antigen-ligand positron emission tomography and low prostate-specific antigen are prognostic factors for a favorable biochemical response to prostate-specific membrane antigen-targeted radioguided surgery in recurrent prostate cancer. European Urology 2019;76(4):517-523. https://doi.org/10.1016/j.eururo.2019.03.045 PDF | BibTeX | RIS | DOI

Maurer T., Horn T., Rauscher I., Kr?nke M., Robu S., Wester H. J., Schottelius M., Haller B., Heck Matthias M., Gschwend J. E., Weber W., Eiber M.. Singul?re Metastase in der PSMA-Liganden PET und niedriger PSA-Wert als pr?operative Pr?diktoren für gutes biochemisches Ansprechen nach PSMA-radioguided surgery beim rezidivierenden Prostatakarzinom [Abstract]. Nuklearmedizin 2019;58(2):108. https://doi.org/10.1055/s-0039-1683480 BibTeX | RIS | DOI

Heck Matthias M., Tauber Robert, Schwaiger Sebastian, Retz Margitta, D'Alessandria Calogero, Maurer Tobias, Gafita Andrei, Wester Hans-Jürgen, Gschwend Jürgen E., Weber Wolfgang A., Schwaiger Markus, Knorr Karina, Eiber Matthias. Treatment outcome, toxicity, and predictive factors for radioligand therapy with 177Lu-PSMA-I&T in metastatic castration-resistant prostate cancer. European Urology 2019;75(6):920-926. https://doi.org/10.1016/j.eururo.2018.11.016 PDF | BibTeX | RIS | DOI

2018

Horn T., Rauscher I., Eiber M., Wester H. J., Schottelius M., Heck Matthias M., Gschwend J. E., Maurer T.. 1221 - Clinical results of salvage PSMA-radioguided surgery in recurrent prostate cancer [Abstract]. European Urology Supplements 2018;17(2):e1708. https://doi.org/10.1016/s1569-9056(18)32036-0 PDF | BibTeX | RIS | DOI

Heck Matthias, Schwaiger S., Knorr K., Retz M., Maurer T., Janssen F., D'Alessandria C., Wester H.-J., Gschwend J., Schwaiger M., Tauber R., Eiber M.. 607 - Radioligand therapy with Lutetium 177-labeled PSMA-I&T for metastatic castration-resistant prostate cancer: clinical experience with 100 consecutive patients [Abstract]. European Urology Supplements 2018;17(2):e874. https://doi.org/10.1016/s1569-9056(18)31442-8 PDF | BibTeX | RIS | DOI

Seitz A.-K., Thoene S., Bietenbeck A., Nawroth R., Tauber R., Thalgott M., Schmid S., Secci R., Retz M., Gschwend J., Ruland J., Winter C., Heck Matthias. 609 - AR-V7 in peripheral whole blood of castration-resistant prostate cancer patients: association with treatment-specific outcome under abiraterone and enzalutamide [Abstract]. European Urology Supplements 2018;17(2):e877. https://doi.org/10.1016/s1569-9056(18)31444-1 PDF | BibTeX | RIS | DOI

Heck Matthias M., Schwaiger Sebastian, Knorr Karina, Retz Margitta, Maurer Tobias, Janssen Friederike, D'Alessandria Calogero, Wester Hans-Juergen, Gschwend Juergen E., Schwaiger Markus, Tauber Robert, Eiber Matthias. Clinical experience with 100 consecutive patients treated with Lu-177-labeled PSMA-I&T radioligand therapy for metastatic castration-resistant prostate cancer [Abstract]. Journal of Clinical Oncology 2018;36(6_suppl):206. https://doi.org/10.1200/jco.2018.36.6_suppl.206 BibTeX | RIS | DOI

Tauber R. L., Knorr K., Schwaiger S., Retz M., Maurer T., D'Alessandria C., Wester H.-J., Gschwend J., Weber W., Schwaiger M., Heck Matthias M., Eiber M.. Clinical experience with 100 consecutive patients treated with Lu-177-labeled PSMA-I&T radioligand therapy for metastatic castration-resistant prostate cancer: final analysis [Abstract]. Annals of Oncology 2018;29(Supplement 8):viii291. https://doi.org/10.1093/annonc/mdy284.040 PDF | BibTeX | RIS | DOI

Niegisch G., Kübler H., Gschwend J. E., Heck Matthias. Diagnostik und operative Therapie des muskelinvasiven Harnblasenkarzinoms. Der Onkologe 2018;24(1):32-39. https://doi.org/10.1007/s00761-017-0299-2 PDF | BibTeX | RIS | DOI

Rauscher Isabel, Düwel Charlotte, Haller Bernhard, Rischpler Christoph, Heck Matthias M., Gschwend Jürgen E., Schwaiger Markus, Maurer Tobias, Eiber Matthias. Efficacy, predictive factors, and prediction nomograms for 68Ga-labeled prostate-specific membrane antigen–ligand positron-emission tomography/computed tomography in early biochemical recurrent prostate cancer after radical prostatectomy. European Urology 2018;73(5):656-661. https://doi.org/10.1016/j.eururo.2018.01.006 PDF | BibTeX | RIS | DOI

Heck Matthias M., Retz Margitta, Bandur Miriam, Souchay Marc, Vitzthum Elisabeth, Weirich Gregor, Schuster Tibor, Autenrieth Michael, Kübler Hubert, Maurer Tobias, Thalgott Mark, Herkommer Kathleen, Gschwend Jürgen E., Nawroth Roman. Molecular lymph node status for prognostic stratification of prostate cancer patients undergoing radical prostatectomy with extended pelvic lymph node dissection. Clinical Cancer Research 2018;24(10):2342-2349. https://doi.org/10.1158/1078-0432.ccr-17-3771 BibTeX | RIS | DOI

Horn Thomas, Rauscher Isabel, Eiber Matthias, Wester Hans-Juergen, Schottelius Margret, Heck Matthias M., Gschwend Juergen E., Maurer Tobias. Oncological and postoperative outcome of salvage PSMA-radioguided surgery in recurrent prostate cancer [Abstract]. Journal of Clinical Oncology 2018;36(6_suppl):270. https://doi.org/10.1200/jco.2018.36.6_suppl.270 BibTeX | RIS | DOI

Thalgott Mark, Düwel Charlotte, Rauscher Isabel, Heck Matthias M., Haller Bernhard, Gafita Andrei, Gschwend Jürgen E., Schwaiger Markus, Maurer Tobias, Eiber Matthias. One-stop-shop whole-body 68Ga-PSMA-11 PET/MRI compared with clinical nomograms for preoperative T and N staging of high-risk prostate cancer. Journal of Nuclear 新万博体育下载_万博体育app【投注官网】icine 2018;59(12):1850-1856. https://doi.org/10.2967/jnumed.117.207696 PDF | BibTeX | RIS | DOI

Heck Matthias, Schwaiger Sebastian, Knorr Karina, Retz Margitta, Maurer Tobias, Janssen Friederike, D'Alessandria Calogero, Wester Hans-Jürgen, Gschwend Jürgen, Schwaiger Markus, Tauber Robert, Eiber Matthias. PD14-01 Clinical experience with Lutetium 17-labeled PSMA-I&T for raioligand therapy in 100 consecutive patients with metastatic castration-resistant prostate cancer [Abstract]. Journal of Urology 2018;199(4S):e304. https://doi.org/10.1016/j.juro.2018.02.787 BibTeX | RIS | DOI

Seitz Anna-Katharina, Thoene Silvia, Bietenbeck Andreas, Nawroth Roman, Tauber Robert, Thalgott Mark, Schmid Sebastian, Secci Ramona, Retz Margitta, Gschwend Jürgen, Ruland Jürgen, Winter Christof, Heck Matthias. PD14-03 Prediction of treatment resistance under abiraterone and enzalutmide via detection of AR-V7 in peripheral whole blood of castration-resistant prostate cancer patients [Abstract]. Journal of Urology 2018;199(4S):e305. https://doi.org/10.1016/j.juro.2018.02.789 BibTeX | RIS | DOI

Heck Matthias, Retz Margitta, Bandur Miriam, Souchay Marc, Vitzthum Elisabeth, Weirich Gregor, Schuster Tibor, Autenrieth Michael, Kübler Hubert, Maurer Tobias, Thalgott Mark, Herkommer Kathleen, Gschwend Jürgen, Nawroth Roman. PD38-09 Molecular lymph node analysis provides superior prognostic information in prostate cancer patients undergoing radical prostatectomy and extended pelvic lymph node dissection in comparison with standard histopathology [Abstract]. Journal of Urology 2018;199(4S):e739-e740. https://doi.org/10.1016/j.juro.2018.02.1756 BibTeX | RIS | DOI

Seitz Anna Katharina, Rauscher Isabel, Haller Bernhard, Kr?nke Markus, Luther Sophia, Heck Matthias M., Horn Thomas, Gschwend Jürgen E., Schwaiger Markus, Eiber Matthias, Maurer Tobias. Preliminary results on response assessment using 68Ga-HBED-CC-PSMA PET/CT in patients with metastatic prostate cancer undergoing docetaxel chemotherapy. European Journal of Nuclear 新万博体育下载_万博体育app【投注官网】icine and Molecular Imaging 2018;45(4):602-612. https://doi.org/10.1007/s00259-017-3887-x PDF | BibTeX | RIS | DOI

2017

Heck Matthias, Retz M., Bandur M., Souchay M., Vitzthum E., Weirich G., Schuster T., Autenrieth M., Kübler H., Maurer T., Thalgott M., Herkommer K., Gschwend J., Nawroth R.. 872 - Prospective comparison of molecular and histopathologic detection of lymph node metastases in prostate cancer patients undergoing radical prostatectomy with extended pelvic lymph node dissection: prediction of biochemical recurrence [Abstract]. European Urology Supplements 2017;16(3):e1517-e1518. https://doi.org/10.1016/s1569-9056(17)30924-7 PDF | BibTeX | RIS | DOI

Seitz Anna Katharina, Thoene Silvia, Bietenbeck Andreas, Nawroth Roman, Tauber Robert, Thalgott Mark, Schmid Sebastian, Secci Ramona, Retz Margitta, Gschwend Jürgen E., Ruland Jürgen, Winter Christof, Heck Matthias M.. AR-V7 in peripheral whole blood of patients with castration-resistant prostate cancer: association with treatment-specific outcome under abiraterone and enzalutamide. European Urology 2017;72(5):828-834. https://doi.org/10.1016/j.eururo.2017.07.024 PDF | BibTeX | RIS | DOI

Heck Matthias M., Thaler Markus A., Schmid Sebastian C., Seitz Anna‐Katharina, Tauber Robert, Kübler Hubert, Maurer Tobias, Thalgott Mark, Hatzichristodoulou Georgios, H?ppner Michael, Nawroth Roman, Luppa Peter B., Gschwend Jürgen E., Retz Margitta. Chromogranin A and neurone-specific enolase serum levels as predictors of treatment outcome in patients with metastatic castration-resistant prostate cancer undergoing abiraterone therapy. BJU International 2017;119(1):30-37. https://doi.org/10.1111/bju.13493 PDF | BibTeX | RIS | DOI

Okamoto Shozo, Thieme Anne, Allmann Jakob, D'Alessandria Calogero, Maurer Tobias, Retz Margitta, Tauber Robert, Heck Matthias M., Wester Hans-Juergen, Tamaki Nagara, Fendler Wolfgang P., Herrmann Ken, Pfob Christian H., Scheidhauer Klemens, Schwaiger Markus, Ziegler Sibylle, Eiber Matthias. Radiation dosimetry for 177Lu-PSMA I&T in metastatic castration-resistant prostate cancer: absorbed dose in normal organs and tumor lesions. Journal of Nuclear 新万博体育下载_万博体育app【投注官网】icine 2017;58(3):445-450. https://doi.org/10.2967/jnumed.116.178483 PDF | BibTeX | RIS | DOI

Heck Matthias M., Retz M., Tauber R., Knorr K., Kratochwil C., Eiber M.. Radionuklidtherapie des Prostatakarzinoms mittels PSMA-Lutetium. Der Urologe 2017;56(1):32-39. https://doi.org/10.1007/s00120-016-0274-3 PDF | BibTeX | RIS | DOI

Schmid Sebastian C., Sathe Anuja, Guerth Ferdinand, Seitz Anna-Katharina, Heck Matthias M., Maurer Tobias, Schwarzenb?ck Sarah M., Krause Bernd J., Schulz Wolfgang A., Stoehr Robert, Gschwend Jürgen E., Retz Margitta, Nawroth Roman. Wntless promotes bladder cancer growth and acts synergistically as a molecular target in combination with cisplatin. Urologic Oncology: Seminars and Original Investigations 2017;35(9):544.e1-544.e10. https://doi.org/10.1016/j.urolonc.2017.04.015 PDF | BibTeX | RIS | DOI Full author list includes the German Bladder Cancer Network. Please see publisher's website for further details.

2016

Sathe A., Wong K. W., Oppolzer I., Von Busch M., Schmid S. C., Seitz A. K., Heck Matthias M., Gschwend J. E., Retz M., Nawroth R.. 1051 Multiple drug induced feedback loops limit the efficacy of PI3K/AKT/mTOR inhibition as a therapy in bladder cancer [Abstract]. European Urology Supplements 2016;15(3):e1051. https://doi.org/10.1016/s1569-9056(16)61052-7 PDF | BibTeX | RIS | DOI

Heck Matthias, Thalgott M., Schmid S., Oh W., Gong Y., Wang L., Zhu J., Seitz A.-K., Porst D., H?ppner M., Retz M., Gschwend J., Nawroth R.. 1072 A 2-gene panel derived from prostate cancer-enhanced transcripts in whole blood is prognostic for survival and predicts treatment benefit in metastatic castration-resistant prostate cancer [Abstract]. European Urology Supplements 2016;15(3):e1072. https://doi.org/10.1016/s1569-9056(16)61073-4 PDF | BibTeX | RIS | DOI

Maurer T., Gschwend J., P?hr L., Rauscher I., Souvatzoglou M., Haller B., Weirich G., Wester H-J., Heck Matthias, Hacker C., Kübler H., Beer A., Schwaiger M., Eiber M.. 558 Diagnostic efficacy of 68Ga-PSMA PET for lymph node staging and metastatic distribution in patients with intermediate to high-risk prostate cancer [Abstract]. European Urology Supplements 2016;15(3):e558, e558a. https://doi.org/10.1016/s1569-9056(16)60560-2 PDF | BibTeX | RIS | DOI

Heck Matthias M., Retz M., Rauscher I., Scheidhauer K., Maurer T., Storz E., Janssen F., D'Alessandria C., Wester H.-J., Gschwend J. E., Schwaiger M., Tauber R., Eiber M.. 769 Initial clinical experience with 177Lu-PSMA I&T radionuclide therapy in patients with metastatic castration-resistant prostate cancer [Abstract]. European Urology Supplements 2016;15(3):e769. https://doi.org/10.1016/s1569-9056(16)60771-6 PDF | BibTeX | RIS | DOI

Heck Matthias M., Thalgott Mark, Schmid Sebastian C., Oh William K., Gong Yixuan, Wang Li, Zhu Jun, Seitz Anna-Katharina, Porst Desiree, H?ppner Michael, Retz Margitta, Gschwend Jürgen E., Nawroth Roman. A 2-gene panel derived from prostate cancer-enhanced transcripts in whole blood is prognostic for survival and predicts treatment benefit in metastatic castration-resistant prostate cancer. The Prostate 2016;76(13):1160-1168. https://doi.org/10.1002/pros.23202 PDF | BibTeX | RIS | DOI

Pyka Thomas, Okamoto Shozo, Dahlbender Marielena, Tauber Robert, Retz Margitta, Heck Matthias, Tamaki Nagara, Schwaiger Markus, Maurer Tobias, Eiber Matthias. Comparison of bone scintigraphy and 68Ga-PSMA PET for skeletal staging in prostate cancer. European Journal of Nuclear 新万博体育下载_万博体育app【投注官网】icine and Molecular Imaging 2016;43(12):2114-2121. https://doi.org/10.1007/s00259-016-3435-0 PDF | BibTeX | RIS | DOI

Maurer Tobias, Gschwend Jürgen E., Rauscher Isabel, Souvatzoglou Michael, Haller Bernhard, Weirich Gregor, Wester Hans-Jürgen, Heck Matthias, Kübler Hubert, Beer Ambros J., Schwaiger Markus, Eiber Matthias. Diagnostic efficacy of 68Gallium-PSMA-PET compared to conventional imaging in lymph node staging of of 130 consecutive patients with intermediate to high-risk prostate cancer. Journal of Urology 2016;195(5):1436-1443. https://doi.org/10.1016/j.juro.2015.12.025 BibTeX | RIS | DOI

Horn Thomas, Zahel Tina, Adt Nathanja, Schmid Sebastian C., Heck Matthias M., Thalgott Mark K., Hatzichristodoulou Georgios, Haller Bernhard, Autenrieth Michael, Kübler Hubert R., Gschwend Jürgen E., Holzapfel Konstantin, Maurer Tobias. Evaluation of computed tomography for lymph node staging in bladder cancer prior to radical cystectomy. Urologia Internationalis 2016;96(1):51-56. https://doi.org/10.1159/000440889 PDF | BibTeX | RIS | DOI

Hatzichristodoulou Georgios, Wagenpfeil Stefan, Weirich Gregor, Autenrieth Michael, Maurer Tobias, Thalgott Mark, Horn Thomas, Heck Matthias, Herkommer Kathleen, Gschwend Jürgen E., Kübler Hubert. Intraoperative frozen section monitoring during nerve-sparing radical prostatectomy: evaluation of partial secondary resection of neurovascular bundles and its effect on oncologic and functional outcome. World Journal of Urology 2016;34(2):229-236. https://doi.org/10.1007/s00345-015-1623-3 PDF | BibTeX | RIS | DOI

Gschwend Juergen E., Heck Matthias M., Lehmann Jan, Ruebben Herbert, Albers Peter, Heidenreich Axel, de Geeter Patrick, Wolff Johannes M., Frohneberg Detlef, Schnoeller Thomas, K?lble Tilman, Stoeckle Michael, Stenzl Arnulf, Mueller Markus, Liehr Uwe-Bernd, Truss Michael, Roth Stephan, Leissner Joachim, Retz Margitta. Limited versus extended pelvic lymphadenectomy in patients with bladder cancer undergoing radical cystectomy: survival results from a prospective, randomized trial (LEA AUO AB 25/02) [Abstract]. Journal of Clinical Oncology 2016;34(15_suppl):4503-4503. https://doi.org/10.1200/jco.2016.34.15_suppl.4503 BibTeX | RIS | DOI

Heck Matthias M., Retz Margitta, D'Alessandria Calogero, Rauscher Isabel, Scheidhauer Klemens, Maurer Tobias, Storz Enno, Janssen Friederike, Schottelius Margret, Wester Hans-Jürgen, Gschwend Jürgen E., Schwaiger Markus, Tauber Robert, Eiber Matthias. Systemic radioligand therapy with 177Lu-labeled prostate-specific membrane antigen ligand for imaging and therapy in patients with metastatic castration-resistant prostate cancer. Journal of Urology 2016;196(2):382-391. https://doi.org/10.1016/j.juro.2016.02.2969 BibTeX | RIS | DOI

2015

Deveci Serkan, Heck Matthias, Tal R., Mulhall J.. 128 Response profiles to men undergoing blinded spermatic cord blocks for chronic orchalgia [Abstract]. Journal of Sexual 新万博体育下载_万博体育app【投注官网】icine 2015;12(Supplement 1):36. https://doi.org/10.1111/jsm.12826 PDF | BibTeX | RIS | DOI

Schmid S. C., Guerth F., Sathe A., Thalgott M., Heck Matthias M., Maurer T., Gschwend J. E., Retz M., Nawroth R.. 35 Autocrine Wnt signaling regulates cell proliferation in bladder cancer [Abstract]. European Urology Supplements 2015;14(2):e35. https://doi.org/10.1016/s1569-9056(15)60038-0 PDF | BibTeX | RIS | DOI

Wang Li, Gong Yixuan, Chippada-Venkata Uma, Heck Matthias M., Retz Margitta, Nawroth Roman, Galsky Matthew, Tsao Che-Kai, Schadt Eric, de Bono Johann, Olmos David, Zhu Jun, Oh William K.. A robust blood gene expression-based prognostic model for castration-resistant prostate cancer. BMC 新万博体育下载_万博体育app【投注官网】icine 2015;13(1):201. https://doi.org/10.1186/s12916-015-0442-0 PDF | BibTeX | RIS | DOI

Heck Matthias M., Gschwend J., Kübler H.. Aktuelle Systemtherapie des metastasierten Prostatakarzinoms. Der Nuklearmediziner 2015;38(2):78-82. https://doi.org/10.1055/s-0035-1545337 BibTeX | RIS | DOI

Thalgott Mark, Rack Brigitte, Eiber Matthias, Souvatzoglou Michael, Heck Matthias M., Kronester Caroline, Andergassen Ulrich, Kehl Victoria, Krause Bernd J., Gschwend Jurgen E., Retz Margitta, Nawroth Roman. Categorical versus continuous circulating tumor cell enumeration as early surrogate marker for therapy response and prognosis during docetaxel therapy in metastatic prostate cancer patients. BMC Cancer 2015;15(1):458. https://doi.org/10.1186/s12885-015-1478-4 PDF | BibTeX | RIS | DOI

Thalgott M., Heck Matthias M., Eiber M., Souvatzoglou M., Hatzichristodoulou G., Kehl V., Krause B. J., Rack B., Retz M., Gschwend J. E., Andergassen U., Nawroth R.. Circulating tumor cells versus objective response assessment predicting survival in metastatic castration-resistant prostate cancer patients treated with docetaxel chemotherapy. Journal of Cancer Research and Clinical Oncology 2015;141(8):1457-1464. https://doi.org/10.1007/s00432-015-1936-z PDF | BibTeX | RIS | DOI

Thalgott Mark, Rack Brigitte, Horn Thomas, Heck Matthias M., Eiber Matthias, Kübler Hubert, Retz Margitta, Gschwend Jürgen E., Andergassen Ulrich, Nawroth Roman. Detection of circulating tumor cells in locally advanced high-risk prostate cancer during neoadjuvant chemotherapy and radical prostatectomy. Anticancer Research 2015;35(10):5679-5685. PDF | BibTeX | RIS | URL

Liaw Bobby Chi-Hung, Chippada-Venkata Uma, Gong Yixuan, Wang Li, Zhu Jun, Heck Matthias M., Tsao Che-Kai, Galsky Matt D., Oh William K.. Influence of prostate cancer disease state and therapeutic selection on peripheral whole-blood RNA signature [Abstract]. Journal of Clinical Oncology 2015;33(15_suppl):5046. https://doi.org/10.1200/jco.2015.33.15_suppl.5046 BibTeX | RIS | DOI

Storz Enno, Retz Margitta, Tauber Robert, Gschwend Jürgen E., Heck Matthias M.. Metastasiertes, kastrationsresistentes Prostatakarzinom: aktuelle Therapiem?glichkeiten individuell abw?gen. Info Onkologie 2015;18(6):46-53. https://doi.org/10.1007/s15004-015-0713-0 BibTeX | RIS | DOI

Sullivan John, Tal Raanan, Heck Matthias, Bernstein Melanie, Nelson Christian, Mulhall John. PD48-01 Peyronie's disease following radical prostatectomy: incidence in a population with formal pre operative assessment [Abstract]. Journal of Urology 2015;193(4S):e966. https://doi.org/10.1016/j.juro.2015.02.2758 BibTeX | RIS | DOI

2014

Hatzichristodoulou G., Heck Matthias, Wagenpfeil S., Herkommer K., Gschwend J. E., Kübler H.. 1065 Influence of the extent of lymph node dissection on erectile function recovery in patients undergoing bilateral nerve-sparing radical prostatectomy: comparative analysis of extended and standard pelvic lymph node dissection [Abstract]. European Urology Supplements 2014;13(1):e1065. https://doi.org/10.1016/s1569-9056(14)61047-2 PDF | BibTeX | RIS | DOI

Thalgott M., Heck Matthias M., Pantel K.. Detektion zirkulierender Tumorzellen im peripheren Blut beim Prostatakarzinom. Der Urologe 2014;53(4):509-513. https://doi.org/10.1007/s00120-014-3444-1 PDF | BibTeX | RIS | DOI

Hatzichristodoulou G., Heck Matthias, Thalgott Mark, Wagenpfeil Stefan, Herkommer Kathleen, Kuebler H., Gschwend J.. HP-06-004 Extended pelvic lymph node dissection during nerve-sparing radical prostatectomy and its effect on erectile function recovery: comparison with standard lymph node dissection [Abstract]. Journal of Sexual 新万博体育下载_万博体育app【投注官网】icine 2014;11(Supplement 1):42. https://doi.org/10.1111/jsm.12415 PDF | BibTeX | RIS | DOI

Thalgott Mark, Horn Thomas, Heck Matthias M., Maurer Tobias, Eiber Matthias, Retz Margitta, Autenrieth Michael, Herkommer Kathleen, Krause Bernd J., Gschwend Jürgen E., Treiber Uwe, Kübler Hubert R.. Long-term results of a phase II study with neoadjuvant docetaxel chemotherapy and complete androgen blockade in locally advanced and high-risk prostate cancer. Journal of Hematology & Oncology 2014;7(1):20. https://doi.org/10.1186/1756-8722-7-20 PDF | BibTeX | RIS | DOI

Heck Matthias M., Gschwend J. E.. Molekulare Diagnostik und molekulares Staging: neue Entwicklungen auf dem Weg in die klinische Praxis?. Der Urologe 2014;53(4):467-468. https://doi.org/10.1007/s00120-014-3477-5 PDF | BibTeX | RIS | DOI

Heck Matthias M., Retz M., Nawroth R.. Molekulares Lymphknotenstaging beim Prostata- und Harnblasenkarzinom. Der Urologe 2014;53(4):484-490. https://doi.org/10.1007/s00120-014-3441-4 PDF | BibTeX | RIS | DOI

Sathe A., Guerth F., Cronauer M. V., Heck Matthias M., Thalgott M., Gschwend J. E., Retz M., Nawroth R.. Mutant PIK3CA controls DUSP1-dependent ERK 1/2 activity to confer response to AKT target therapy. British Journal of Cancer 2014;111(11):2103-2113. https://doi.org/10.1038/bjc.2014.534 PDF | BibTeX | RIS | DOI

Schrempf M. C., Horn T., Heck Matthias, Maurer T., Thalgott M., Autenrieth M., Gschwend J. E., Kübler H.. PE13: Initial experience of robotic assisted retroperitoneoscopic partial nephrectomy [Poster abstract]. European Urology Supplements 2014;13(3):20. https://doi.org/10.1016/s1569-9056(14)50204-7 PDF | BibTeX | RIS | DOI

Vag Tibor, Heck Matthias M., Beer Ambros J., Souvatzoglou Michael, Weirich Gregor, Holzapfel Konstantin, Krause Bernd Joachim, Schwaiger Markus, Eiber Matthias, Rummeny Ernst J.. Preoperative lymph node staging in patients with primary prostate cancer: comparison and correlation of quantitative imaging parameters in diffusion-weighted imaging and 11C-choline PET/CT. European Radiology 2014;24(8):1821-1826. https://doi.org/10.1007/s00330-014-3240-8 PDF | BibTeX | RIS | DOI Erratum published at https://doi.org/10.1007/s00330-014-3282-y

Maurer Tobias, Horn Thomas, Souvatzoglou Michael, Eiber Matthias, Beer Ambros J., Heck Matthias M., Haller Bernhard, Gschwend Jürgen E., Schwaiger Markus, Treiber Uwe, Krause Bernd J.. Prognostic value of C-11-choline PET/CT and CT for predicting survival of bladder cancer patients treated with radical cystectomy. Urologia Internationalis 2014;93(2):207-213. https://doi.org/10.1159/000357686 PDF | BibTeX | RIS | DOI

Heck Matthias M., Souvatzoglou Michael, Retz Margitta, Nawroth Roman, Kübler Hubert, Maurer Tobias, Thalgott Mark, Gramer Bettina M., Weirich Gregor, Rondak Ina-Christine, Rummeny Ernst J., Schwaiger Markus, Gschwend Jürgen E., Krause Bernd, Eiber Matthias. Prospective comparison of computed tomography, diffusion-weighted magnetic resonance imaging and [11C]choline positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer patients. European Journal of Nuclear 新万博体育下载_万博体育app【投注官网】icine and Molecular Imaging 2014;41(4):694-701. https://doi.org/10.1007/s00259-013-2634-1 PDF | BibTeX | RIS | DOI

Heck Matthias M., Retz Margitta, Bandur Miriam, Souchay Marc, Vitzthum Elisabeth, Weirich Gregor, Mollenhauer Martin, Schuster Tibor, Autenrieth Michael, Kübler Hubert, Maurer Tobias, Thalgott Mark, Herkommer Kathleen, Gschwend Jürgen E., Nawroth Roman. Topography of lymph node metastases in prostate cancer patients undergoing radical prostatectomy and extended lymphadenectomy: results of a combined molecular and histopathologic mapping study. European Urology 2014;66(2):222-229. https://doi.org/10.1016/j.eururo.2013.02.007 PDF | BibTeX | RIS | DOI

2013

Hatzichristodoulou G., Weirich G., Wagenpfeil S., Herkommer K., Autenrieth M., Maurer T., Thalgott M., Horn T., Heck Matthias, Gschwend J. E., Kübler H.. 809 Ink marked intraoperative frozen section of the prostate during open radical prostatectomy – prospective analysis of diagnostic and therapeutic efficacy [Abstract]. European Urology Supplements 2013;12(1):e809. https://doi.org/10.1016/s1569-9056(13)61289-0 PDF | BibTeX | RIS | DOI

Maurer Tobias, Horn Thomas, Heck Matthias, Gschwend Jürgen E., Eiber Matthias, Beer Ambros J.. Current staging procedures in urinary bladder cancer. Diagnostics 2013;3(3):315-324. https://doi.org/10.3390/diagnostics3030315 PDF | BibTeX | RIS | DOI

Thalgott Mark, Rack Brigitte, Maurer Tobias, Souvatzoglou Michael, Eiber Matthias, Kre? Veronika, Heck Matthias M., Andergassen Ulrich, Nawroth Roman, Gschwend Jürgen E., Retz Margitta. Detection of circulating tumor cells in different stages of prostate cancer. Journal of Cancer Research and Clinical Oncology 2013;139(5):755-763. https://doi.org/10.1007/s00432-013-1377-5 PDF | BibTeX | RIS | DOI

Heck Matthias M., Gschwend Jürgen E., Retz Margitta. Enzalutamide (formerly MDV3100) prolongs survival in docetaxel-pretreated castration-resistant prostate cancer patients [Editorial]. TAU - Translational Andrology and Urology 2013;2(2):92-93. https://doi.org/10.3978/j.issn.2223-4683.2012.11.02 PDF | BibTeX | RIS | DOI

Maurer Tobias, Pournaras Christos, Aguilar-Pimentel Juan A., Thalgott Mark, Horn Thomas, Heck Matthias, Heit Antje, Kuebler Hubert, Gschwend Jürgen E., Nawroth Roman. Immunostimulatory CpG-DNA and PSA-peptide vaccination elicits profound cytotoxic T cell responses. Urologic Oncology: Seminars and Original Investigations 2013;31(7):1395-1401. https://doi.org/10.1016/j.urolonc.2011.09.002 PDF | BibTeX | RIS | DOI

Tauber Robert, Schmid Sebastian, Horn Thomas, Thalgott Mark, Heck Matthias, Haller Bernhard, Kübler Hubert, Autenrieth Michael, Retz Margitta, Gschwend Jürgen E., Maurer Tobias. Inguinal lymph node dissection: epidermal vacuum therapy for prevention of wound complications. Journal of Plastic, Reconstructive & Aesthetic Surgery 2013;66(3):390-396. https://doi.org/10.1016/j.bjps.2012.09.030 PDF | BibTeX | RIS | DOI

2012

Heck Matthias M., Nawroth R., Bandur M., Souchay M., Vitzthum L., Weirich G., Schuster T., Thalgott M., Gschwend J., Retz M.. 1013 Topography of molecularbiological micrometastases in lymph nodes of prostate cancer patients treated with radical prostatectomy and extended lymphadenectomy [Abstract]. European Urology Supplements 2012;11(1):e1013, e1013a. https://doi.org/10.1016/s1569-9056(12)61009-4 PDF | BibTeX | RIS | DOI

Heck Matthias, Thalgott Mark, Retz Margitta, Wolf Petra, Maurer Tobias, Gschwend Jürgen, Kübler Hubert. 680 Prediction of favourable outcome and rational indication of docetaxel rechallenge in metastatic castration-resistant prostate cancer [Abstract]. Journal of Urology 2012;187(4S):e277. https://doi.org/10.1016/j.juro.2012.02.762 BibTeX | RIS | DOI

Heck Matthias M., H?ppner M., Horn T., Thalgott M., Gschwend J. E., Retz M.. Abiraterone- und Cabazitaxel-H?rtefallprogramm: erste klinische Erfahrungen bei Docetaxel-vorbehandelten kastrationsresistenten Prostatakarzinompatienten. Der Urologe 2012;51(3):390-397. https://doi.org/10.1007/s00120-012-2804-y PDF | BibTeX | RIS | DOI

Mazzola Clarisse R., Deveci Serkan, Heck Matthias, Mulhall John P.. Androgen deprivation therapy before radical prostatectomy is associated with poorer postoperative erectile function outcomes. BJU International 2012;110(1):112-116. https://doi.org/10.1111/j.1464-410x.2011.10728.x PDF | BibTeX | RIS | DOI

Heck Matthias M., Gschwend J. E., Retz M.. Chemotherapie beim Harnblasenkarzinom: Update 2012 - aus AUO (Arbeitsgemeinschaft Urologische Onkologie) und IABC (Interdisziplin?re Arbeitsgruppe BlasenCarcinom). Der Urologe 2012;51(6):829-836. https://doi.org/10.1007/s00120-012-2822-9 PDF | BibTeX | RIS | DOI

Heck Matthias M., Kron Martina, Gschwend Jürgen E., Herkommer Kathleen. Effect of family history on outcome in German patients treated with radical prostatectomy for clinically localised prostate cancer. European Journal of Cancer 2012;48(9):1312-1317. https://doi.org/10.1016/j.ejca.2011.10.002 PDF | BibTeX | RIS | DOI

Ohlmann Carsten Henning, St?ckle Michael, Pfister David A., Heidenreich Axel, Merseburger Axel S., Kuczyk Markus, Manka Lukas, Hammerer Peter, Albers Peter, Arsov Christian, Retz Margitta, Gschwend Jürgen E., Feyerabend Susan, Stenzl Arnulf, Banek Severine, Marin Jan, Gleissner Jochen, Wirth Manfred, Zastrow Stefan, Heck Matthias. Efficacy of abiraterone acetate in the treatment of castration-resistant prostate cancer: early results from the German compassionate-use program [Abstract]. Journal of Clinical Oncology 2012;30(15_suppl):e15195. https://doi.org/10.1200/jco.2012.30.15_suppl.e15195 BibTeX | RIS | DOI

Heck Matthias M., Thalgott Mark K., Retz Margitta, Wolf Petra, Maurer Tobias, Gschwend Juergen, Kuebler Hubert. Prediction of favorable outcome in a docetaxel rechallenge setting in metastatic castration-resistant prostate cancer [Abstract]. Journal of Clinical Oncology 2012;30(5_suppl):68. https://doi.org/10.1200/jco.2012.30.5_suppl.68 BibTeX | RIS | DOI

Heck Matthias M., Thalgott Mark, Retz Margitta, Wolf Petra, Maurer Tobias, Nawroth Roman, Hatzichristodoulou Georgios, Gschwend Jürgen E., Kübler Hubert. Rational indication for docetaxel rechallenge in metastatic castration‐resistant prostate cancer. BJU International 2012;110(11b):E635-E640. https://doi.org/10.1111/j.1464-410x.2012.11364.x PDF | BibTeX | RIS | DOI

2011

Heck Matthias, Nawroth Roman, Bandur Miriam, Vitzthum Lisa, Souchay Marc, Schuster Tibor, Weirich Gregor, Thalgott Mark, Gschwend Jürgen, Retz Margitta. 2332 Detection and topography of micrometastases in lymph nodes of prostate cancer patients treated with radical prostatectomy and extended lymphadenectomy using quantitative PCR [Abstract]. Journal of Urology 2011;185(4S):e935. https://doi.org/10.1016/j.juro.2011.02.2579 BibTeX | RIS | DOI

2010

Stember D. S., Logmanieh N., Heck Matthias, Mulhall J. P.. 041 Serum androgen profiles in men with secondary retarded orgasm [Abstract]. The Journal of Sexual 新万博体育下载_万博体育app【投注官网】icine 2010;7(Supplement_4):165. https://doi.org/10.1111/j.1743-6109.2010.01995_1.x PDF | BibTeX | RIS | DOI

Mueller A., Heck Matthias, Mulhall J. P.. 071 Patterns of venous leak during cavernosometry [Abstract]. The Journal of Sexual 新万博体育下载_万博体育app【投注官网】icine 2010;7(Supplement_4):175. https://doi.org/10.1111/j.1743-6109.2010.01995_1.x PDF | BibTeX | RIS | DOI

Herkommer K., Heck Matthias M., Winkler C., Gschwend J. E., Kron M.. 1006 Long term progression-free, overall and cancer-specific survival in familial cancer patients in Germany [Poster abstract]. European Urology Supplements 2010;9(2):315. https://doi.org/10.1016/s1569-9056(10)60985-2 PDF | BibTeX | RIS | DOI

Stember Doron S., Logmanieh Nina, Heck Matthias, Mulhall John P.. 1205 Testosterone profiles in men with secondary retarded orgasm [Abstract]. Journal of Urology 2010;183(4S):e467. https://doi.org/10.1016/j.juro.2010.02.707 BibTeX | RIS | DOI

Heck Matthias, Kron Martina, Gschwend Jürgen, Herkommer Kathleen. 298 Impact of familial status and risk group classification in patients with localized prostate cancer on progression free survival after radical prostatectomy [Abstract]. Journal of Urology 2010;183(4S):e118. https://doi.org/10.1016/j.juro.2010.02.361 BibTeX | RIS | DOI

Thalaott M. K., Treiber U., Maurer T., Heck Matthias, Eiber M., Reimer B., Herkommer K., Paul R., Retz M., Gschwend J. E., Kübier H.. 688 Neoadjuvant combination therapy of docetaxeland complete androgen deprivation for localized high risk prostate cancer before radical prostatectomy [Poster abstract]. European Urology Supplements 2010;9(2):226. https://doi.org/10.1016/s1569-9056(10)60675-6 PDF | BibTeX | RIS | DOI

Thalaott M. K., Nawroth R., Andergassen U., Rack B. K., Maurer T., Heck Matthias, Horn T., Herkommer K., Gschwend J. E., Retz M.. 868 Pilot trial for the quantitative detection of circulating tumor cells in patients with prostate cancer [Poster abstract]. European Urology Supplements 2010;9(2):275. https://doi.org/10.1016/s1569-9056(10)60850-0 PDF | BibTeX | RIS | DOI

Heck Matthias M., Gschwend J. E., Retz M.. Chemotherapie beim Harnblasenkarzinom: Update 2010. Der Urologe 2010;49(10):1294-1300. https://doi.org/10.1007/s00120-010-2380-y PDF | BibTeX | RIS | DOI

Tal Raanan, Heck Matthias, Teloken Patrick, Siegrist Timothy, Nelson Christian J., Mulhall John P.. Peyronie's disease following radical prostatectomy: incidence and predictors. The Journal of Sexual 新万博体育下载_万博体育app【投注官网】icine 2010;7(3):1254-1261. https://doi.org/10.1111/j.1743-6109.2009.01655.x PDF | BibTeX | RIS | DOI

2009

Schneider Lutz, Hackert Thilo, Heck Matthias, Hartwig Werner, Fritz Stefan, Strobel Oliver, Gebhard Martha-Maria, Werner Jens. Capsaicin reduces tissue damage in experimental acute pancreatitis. Pancreas 2009;38(6):676-680. https://doi.org/10.1097/mpa.0b013e3181a5ef3a BibTeX | RIS | DOI

Deveci Serkan, Heck Matthias, Parker Marilyn, Guhring Patricia, Mulhall John P.. Pre-radical prostatectomy (RP) androgen deprivation therapy (ADT) is associated with poorer postoperative erectile function outcomes [Abstract]. Journal of Urology 2009;181(4S):525. https://doi.org/10.1016/s0022-5347(09)61482-8 BibTeX | RIS | DOI

Schneider Lutz, Hartwig Werner, Flemming Thomas, Hackert Thilo, Fortunato Franco, Heck Matthias, Gebhard Martha-Maria, Nawroth Peter P., Bierhaus Angelika, Büchler Markus W., Werner Jens. Protective effects and anti-inflammatory pathways of exogenous calcitonin gene-related peptide in severe necrotizing pancreatitis. Pancreatology 2009;9(5):662-669. https://doi.org/10.1159/000212099 PDF | BibTeX | RIS | DOI

2008

Heck Matthias, Nelson Christian, Eastham James A., Rabbani Farhang, Touijer Karim, Guillonneau Bertrand D., Scardino Peter T., Mulhall John P.. 729 Analyzing the occurrence of Peyronie's disease after radical prostatectomy [Abstract]. Journal of Urology 2008;179(4):255. BibTeX | RIS | URL

Heck Matthias. Wirkung von endogen freigesetztem CGRP durch Gabe von exogenem Capsaicin auf die akute experimentelle Pankreatitis im Rattenmodell. Heidelberg: Universit?t Heidelberg; 2008. BibTeX | RIS | URL Dissertation, Universit?t Heidelberg, 2008

2006

Hackert Thilo, Schneider L., Heck Matthias, Hartwig Werner, Gebhard M. M., Werner Jens. Exogenous capsaicin application induces endogenous CGRP liberation and attenuates acute experimental pancreatitis [Abstract]. Pancreas 2006;33(4):466. https://doi.org/10.1097/00006676-200611000-00100 BibTeX | RIS | DOI